127 related articles for article (PubMed ID: 37068312)
1. Structural analysis of factors related to FAM3C/ILEI dimerization and identification of inhibitor candidates targeting cancer treatment.
Flores RMA; Pantaleão SQ; Araujo SC; Malpartida HMG; Honorio KM
Comput Biol Chem; 2023 Jun; 104():107869. PubMed ID: 37068312
[TBL] [Abstract][Full Text] [Related]
2. Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasis.
Kral M; Klimek C; Kutay B; Timelthaler G; Lendl T; Neuditschko B; Gerner C; Sibilia M; Csiszar A
FEBS J; 2017 Oct; 284(20):3484-3505. PubMed ID: 28837266
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer.
Jansson AM; Csiszar A; Maier J; Nyström AC; Ax E; Johansson P; Schiavone LH
J Biol Chem; 2017 Sep; 292(37):15501-15511. PubMed ID: 28751379
[TBL] [Abstract][Full Text] [Related]
4. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
[TBL] [Abstract][Full Text] [Related]
5. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
Woosley AN; Dalton AC; Hussey GS; Howley BV; Mohanty BK; Grelet S; Dincman T; Bloos S; Olsen SK; Howe PH
Oncogene; 2019 May; 38(20):3794-3811. PubMed ID: 30692635
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1).
Noguchi K; Dincman TA; Dalton AC; Howley BV; McCall BJ; Mohanty BK; Howe PH
J Biol Chem; 2018 Jul; 293(29):11401-11414. PubMed ID: 29871931
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
9. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
[TBL] [Abstract][Full Text] [Related]
10. ILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549.
Song Q; Sheng W; Zhang X; Jiao S; Li F
Tumour Biol; 2014 Feb; 35(2):1377-82. PubMed ID: 24072492
[TBL] [Abstract][Full Text] [Related]
11. FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1.
Yang W; Feng B; Meng Y; Wang J; Geng B; Cui Q; Zhang H; Yang Y; Yang J
J Cell Mol Med; 2019 May; 23(5):3464-3475. PubMed ID: 30887707
[TBL] [Abstract][Full Text] [Related]
12. FAM3B PANDER and FAM3C ILEI represent a distinct class of signaling molecules with a non-cytokine-like fold.
Johansson P; Bernström J; Gorman T; Oster L; Bäckström S; Schweikart F; Xu B; Xue Y; Schiavone LH
Structure; 2013 Feb; 21(2):306-13. PubMed ID: 23333428
[TBL] [Abstract][Full Text] [Related]
13.
Zhu Y; Pu Z; Wang G; Li Y; Wang Y; Li N; Peng F
Biomark Med; 2021 Apr; 15(5):373-384. PubMed ID: 33666514
[TBL] [Abstract][Full Text] [Related]
14. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
[TBL] [Abstract][Full Text] [Related]
15. ILEI is an important intermediate participating in the formation of TGF-β1-induced renal tubular EMT.
Zhao X; Luo G; Fan Y; Ma X; Zhou J; Jiang H
Cell Biochem Funct; 2018 Mar; 36(2):46-55. PubMed ID: 29336056
[TBL] [Abstract][Full Text] [Related]
16. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression.
Lahsnig C; Mikula M; Petz M; Zulehner G; Schneller D; van Zijl F; Huber H; Csiszar A; Beug H; Mikulits W
Oncogene; 2009 Feb; 28(5):638-50. PubMed ID: 19015638
[TBL] [Abstract][Full Text] [Related]
17. FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.
Thuya WL; Kong LR; Syn NL; Ding LW; Cheow ESH; Wong RTX; Wang T; Goh RMW; Song H; Jayasinghe MK; Le MT; Hu JC; Yong WP; Lee SC; Wong AL; Sethi G; Hung HT; Ho PC; Thiery JP; Sze SK; Guo T; Soo RA; Yang H; Lim YC; Wang L; Goh BC
Theranostics; 2023; 13(2):621-638. PubMed ID: 36632230
[No Abstract] [Full Text] [Related]
18. Extracellular Release of ILEI/FAM3C and Amyloid-β Is Associated with the Activation of Distinct Synapse Subpopulations.
Nakano M; Mitsuishi Y; Liu L; Watanabe N; Hibino E; Hata S; Saito T; Saido TC; Murayama S; Kasuga K; Ikeuchi T; Suzuki T; Nishimura M
J Alzheimers Dis; 2021; 80(1):159-174. PubMed ID: 33492290
[TBL] [Abstract][Full Text] [Related]
19. The FAM3 superfamily member ILEI ameliorates Alzheimer's disease-like pathology by destabilizing the penultimate amyloid-β precursor.
Hasegawa H; Liu L; Tooyama I; Murayama S; Nishimura M
Nat Commun; 2014 Jun; 5():3917. PubMed ID: 24894631
[TBL] [Abstract][Full Text] [Related]
20. Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice.
Schmidt U; Uluca B; Vokic I; Malik B; Kolbe T; Lassnig C; Holcmann M; Moreno-Viedma V; Robl B; Mühlberger C; Gotthardt D; Sibilia M; Rülicke T; Müller M; Csiszar A
PLoS One; 2023; 18(9):e0286256. PubMed ID: 37713409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]